Tick-transmitted co-infections among erythema migrans patients in a general practice setting in Norway: a clinical and laboratory follow-up study

Table 2 Overview of the EM patients displaying antibody reactivity against tick-borne microorganisms other than Bbsl

Case	Sex	Age	Microorganism and antibody class	Serology 1 at day 0 (baseline)	Serology 2 at day 14	Serology 3 after three months	Serology 4 after 12 months	Bb. IgG 3 m
1	F	67	SFGR IgG	< 1:64	NA	1:128	1:128	POS
			SFGR IgM	< 1:64	NA	< 1:64	1:256
			Ap IgG	1:64	NA	1:128	1:64
			Ap IgM	< 1:20	NA	< 1:20	< 1:20
2	M	27	SFGR IgG	< 1:64	1:128	–	–	–
2	M	27	SFGR IgM	< 1:64	< 1:64	–	–	–
3	M	85	SFGR IgG	< 1:64	< 1:64	1:128	1:128	POS
3	M	85	SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64	POS
4	F	50	SFGR IgG	< 1:64	< 1:64	1:128	< 1:64	POS
4	F	50	SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64	POS
5	M	65	SFGR IgG	1:1024	1:1024	1:256	1:512	POS
5	M	65	SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64	POS
6	F	59	SFGR IgG	1:512	1:1024	1:512	1:1024	NEG
			SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64
			Ap IgG	1:128	1:128	1:128	1:64
			Ap IgM	< 1:20	< 1:20	< 1:20	< 1:20
7	F	49	SFGR IgG	1:512	1:512	1:512	1:1024	NEG
			SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64
			Ap IgG	1:128	1:128	1:128	1:128
			Ap IgM	< 1:20	< 1:20	< 1:20	< 1:20
8	M	24	SFGR IgG	1:2048	1:2048	-	-	-
8	M	24	SFGR IgM	< 1:64	< 1:64	-	-	-
9	M	76	SFGR IgG	1:512	1:512	1:256	1:256	POS
9	M	76	SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64	POS
10	F	51	SFGR IgG	1:4096	1:4096	1:4096	1:4096	POS
10	F	51	SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64	POS
11	M	49	SFGR IgG	1:512	1:512	1:256	1:512	NEG
11	M	49	SFGR IgM	< 1:64	< 1:64	< 1:64	< 1:64	NEG
12	F	76	Ap IgG	1:64	1:64	1:128	1:64	POS
12	F	76	Ap IgM	< 1:20	< 1:20	< 1:20	< 1:20	POS
13	F	60	Ap IgG	1:128	1:128	1:64	1:64	POS
13	F	60	Ap IgM	< 1:20	< 1:20	< 1:20	< 1:20	POS
14	F	59	Ap IgG	1:64	1:128	1:128	1:128	POS
14	F	59	Ap IgM	< 1:20	< 1:20	< 1:20	< 1:20	POS
15	M	55	Ap IgG	1:64	1:64	1:64	1:128	NEG
15	M	55	Ap IgM	< 1:20	< 1:20	< 1:20	< 1:20	NEG
16	M	50	Ap IgG	1:128	1:128	1:64	1:128	POS
16	M	50	Ap IgM	1:40	1:40	< 1:20	20	POS

The titer values of the four patients displaying a fourfold rise in anti-Rickettsia IgG are printed in boldface
SFGR spotted fever group Rickettsia, Ap Anaplasma phagocytophilum

ISSN: 1471-2334